Crossmark

Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study)

Crossref DOI link: https://doi.org/10.1186/s12904-023-01330-1

Published Online: 2024-01-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hirschinger, Hanna

Jaeger, Evelyn

Nittka, Stefanie

Hetjens, Svetlana

Lorenz, Christine

Remi, Constanze

Saussele, Susanne

Hofmann, Wolf-K.

Gencer, Deniz

Boch, Tobias
Funding

Funding for this research was provided by:

Medizinische Fakultät Mannheim der Universität Heidelberg
License Information

Text and Data Mining valid from 2024-01-03

Version of Record valid from 2024-01-03
More Information

Article History

Received: 25 October 2023

Accepted: 14 December 2023

First Online: 3 January 2024

Declarations

:

: The authors declare no competing interests.

: Ethics approval: 2022-4 monocentre. Written, informed consent to participate will be obtained from all participants. We confirm that all experiments are performed in accordance with relevant guidelines and regulations (the Declaration of Helsinki and Good Clinical Practice). The trial was approved and registered by the regulatory authorities in accordance with the legal requirements.

: University of Heidelberg.

: Not applicable.

Document is current

Any future updates will be listed below